These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 36231062)

  • 21. The RASopathies: Biology, genetics and therapeutic options.
    Longo JF; Carroll SL
    Adv Cancer Res; 2022; 153():305-341. PubMed ID: 35101235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Noonan syndrome phenotype associated with a germline Q71R MRAS variant: a recurrent substitution in RAS homologs in various cancers.
    Suzuki H; Takenouchi T; Uehara T; Takasago S; Ihara S; Yoshihashi H; Kosaki K
    Am J Med Genet A; 2019 Aug; 179(8):1628-1630. PubMed ID: 31173466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New insight of craniofacial and oral findings of the RASopathies].
    Cao HT; Yang YJ; Zheng Q; Shi B; Li CH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Dec; 53(12):858-861. PubMed ID: 30522213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
    Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
    Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Genetics of Noonan Syndrome and RASopathies.
    Liao J; Mehta L
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.
    Edwards JJ; Martinelli S; Pannone L; Lo IF; Shi L; Edelmann L; Tartaglia M; Luk HM; Gelb BD
    Am J Med Genet A; 2014 Sep; 164A(9):2351-5. PubMed ID: 24891296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
    Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY
    BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTPN11-associated mutations in the heart: has LEOPARD changed Its RASpots?
    Lauriol J; Kontaridis MI
    Trends Cardiovasc Med; 2011 May; 21(4):97-104. PubMed ID: 22681964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Growth Failure in Rasopathies.
    Aftab S; Dattani MT
    Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):447-458. PubMed ID: 31115196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral profile in RASopathies.
    Alfieri P; Piccini G; Caciolo C; Perrino F; Gambardella ML; Mallardi M; Cesarini L; Leoni C; Leone D; Fossati C; Selicorni A; Digilio MC; Tartaglia M; Mercuri E; Zampino G; Vicari S
    Am J Med Genet A; 2014 Apr; 164A(4):934-42. PubMed ID: 24458522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [RIT1: a novel gene associated with Noonan syndrome].
    Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
    Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
    Gross AM; Frone M; Gripp KW; Gelb BD; Schoyer L; Schill L; Stronach B; Biesecker LG; Esposito D; Hernandez ER; Legius E; Loh ML; Martin S; Morrison DK; Rauen KA; Wolters PL; Zand D; McCormick F; Savage SA; Stewart DR; Widemann BC; Yohe ME
    Am J Med Genet A; 2020 Apr; 182(4):866-876. PubMed ID: 31913576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.
    Kouz K; Lissewski C; Spranger S; Mitter D; Riess A; Lopez-Gonzalez V; Lüttgen S; Aydin H; von Deimling F; Evers C; Hahn A; Hempel M; Issa U; Kahlert AK; Lieb A; Villavicencio-Lorini P; Ballesta-Martinez MJ; Nampoothiri S; Ovens-Raeder A; Puchmajerová A; Satanovskij R; Seidel H; Unkelbach S; Zabel B; Kutsche K; Zenker M
    Genet Med; 2016 Dec; 18(12):1226-1234. PubMed ID: 27101134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraspinal neurofibromas and hypertrophic neuropathy in Noonan syndrome with multiple lentigines.
    Conboy E; Dhamija R; Wang M; Xie J; Dyck PJ; Bridges AG; Spinner RJ; Clayton AC; Watson RE; Messiaen L; Babovic-Vuksanovic D
    J Med Genet; 2016 Feb; 53(2):123-6. PubMed ID: 26337637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11.
    van Nierop JWI; van Trier DC; van der Burgt I; Draaisma JMT; Mylanus EAM; Snik AF; Admiraal RJC; Kunst HPM
    Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():228-234. PubMed ID: 28483241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
    Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
    Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile xanthogranuloma in Noonan syndrome.
    Ali MM; Gilliam AE; Ruben BS; Tidyman WE; Rauen KA
    Am J Med Genet A; 2021 Oct; 185(10):3048-3052. PubMed ID: 34032360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.